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Abstract 
 
Rationale and objective:The major objective of treatment in glaucomatous disease is the decrease of intraocular pressure while 
maintaining the patient's vision and quality of life. Despite therapeutic possibilities, some cases of glaucoma remain refractory to 
treatment with the maintenance of elevated intraocular pressure and further progression of the disease. 
Artificial drainage systems, Ahmed valve, is a treatment alternative for refractory glaucoma when medical therapy, laser or 
conventional surgery have shown no results. 
Methods and results: We present the case of a patient presenting with refractive to medical treatment secondary glaucoma, 
following cataract surgery and vitrectomy for retinal detachment. 
Discussions: One of the complications of vitreoretinal surgery is secondary glaucoma. Some of the patients with this type of 
glaucoma are unresponsive to conventional medical therapy. In such situations, a DPS implantation is needed such as an Ahmed 
valve in our case.  
There are situations in which classical surgery-trabeculectomy - has no theoretical chance of success (in cases of neovascular 
glaucoma, secondary glaucoma, and inflammatory glaucoma post vitreoretinal surgery), [5,6]. Even though ASD are only used for 
refractory glaucoma, in this type of glaucoma, ADS can be used successfully as first line surgery. 
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Abbreviations 
ADS = artificial drainage system; IOP = intraocular pressure; BCVA = best correct visual acuity; CA inhibitor = carbonic anhydrase 
inhibitor; OCT = optical coherence tomography 
Introduction 
Increased ocular pressure (over 22 mmHg) 
determines, in time, irreversible damage to the optic 
nerve. 
During vitreoretinal surgery, silicone oil is 
sometimes used for a long term tamponade. This silicone 
oil is removed after 3-4 months, as it can give rise to 
various complications, including glaucoma. The 
mechanism described in the development of glaucoma in 
patients with silicone oil tamponade consists of silicone oil 
pupillary block [3,4]. 
Even after these patients have had peripheral 
iridectomy, the development rate of secondary glaucoma 
is reported to be between 5.9% and 56%. [1-3] The 
mechanisms of increased intraocular pressure are 
complex, the blockage of the angle with emulsified oil 
being an important one. Most of these cases are handled 
by extracting the silicon oil (risk of retina redetachment) 
and management of glaucoma. Trabeculectomy has a 
poor prognosis in patients with removal of silicone oil 
because of the high risk of recurrence of retinal 
detachment due to hypotony. 
Case report 
Male patient, age 64 years, presents in January 
2011, with a diagnosis of refractory secondary glaucoma. 
Ophthalmologic history: 
  BE small myopia( RE -1.25DSf ; LE-3DSf) 
  November 2009 RE Cataract surgery with PC 
IOL 
  November 2009 RE (after cataract surgery) 
develops retinal detachment; retinal detachment 
is solved by pars plana vitrectomy and 
endotamponament with silicone oil.  
  July 2010 silicone oil is removed and intraocular 
hypertension is diagnosed.  
Between November and July the patient had no ocular 
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compensating pressure values. The patient was admitted 
for investigation and conduct therapeutic setting. 
Clinical examination at 8 A.M. in January 2011: 
  BCVA RE 0,2; BCVA LE 0,8 
  IOP RE 43 mmHg; LE 20 mmHg with topical 
treatment (beta-blocker, analogue of 
prostaglandin). 
  Pahimetry RE AVG 575, corrected IOP -2; 
LE AVG 567, corrected IOP -1 
  Visual field RE: narrowed nasal 10-15 degrees, 
superior 30 degrees, temporal 60 degrees, 
inferior 30 degrees; LE normal. 
  OCT RNFL RE decreased in all 4 quadrants; LE 
deceased nasal and inferior (due to myopia) 
  Ultrasound examination: RE attached retina, 
traces of silicone oil. 
We added to the treatment carbonic anhydrate 
inhibitor (eye drops form) and obtained IOP RE 20 mmHg, 
corrected IOP 18 mmHg pressure measured at 12 hours. 
 
After one month, in February 2011: 
Clinical examination at 8 in the morning: 
  BCVA RE 0,2; BCVA LE 0,8. 
  IOP RE 34 mmHg; LE 20 mmHg with topical 
treatment (beta-blocker, analogue of 
prostaglandin, CA inhibitor, alpha-blocker). 
  Pahimetry RE AVG 575, corrected IOP -2; 
LE AVG 567, corrected IOP -1. 
  Visual field RE narrowed nasal 10 degrees, 
superior 30 degrees, temporal 50 degrees, 
inferior 30 degrees; LE normal. 
  Gonioscopy: of the RE revealed multiple anterior 
synechiae and pigmentary dispersion in nasal, 
inferior, temporal fields and emulsified silicon oil 
in the superior field. LE multiple anterior 
synechiae nasal and pigmentary dispersion in 
inferior, temporal and superior fields. 
The next day, at 8 AM, RE IOP = 32 mmHg after receiving 
the same local treatment. 
Fluctuations of the intraocular pressure were 
observed during the day with elevated IOP in the morning 
and the presence of emulsified oil at a slight angle 
examination. Patient also presented visual field loss [7, 8]. 
We decided to implant an Ahmed valve in the 
RE. The usual technique with positioning the implant in 
the superior temporal quadrant with scleral flap (patient 
had a good conjunctiva and sclera) is used.  
Postoperative, no complications were noted. 
Patient presented dyplopia during eye movement that 
disappeared in the primary position of the eyeballs.  
At discharge, the valve was covered with 
conjunctiva; the tube was present in the anterior chamber, 
with clear aqueous humor. The valve was functional, RE 
IOP 10 mmHg without medication. 
The recommendations were topical treatment 
with antibiotic and corticosteroid at RE; at LE, anti 
glaucoma medical treatment with prostaglandin 
analogues associated with beta-blockers and carbonic 
anhydrase inhibitors. 
 
After one month, March 2011:  
  BCVA  RE 0,2 ; BCVA LE 0,8 
  IOP RE 12 mmHg (without treatment) LE 18 
mmHg with topical treatment (beta-blocker, 
analogue of prostaglandin, CA inhibitor) 
  Visual field BE is the same 
  Gonioscopy: RE multiple anterior synechiae and 
pigmentary dispersion in nasal, inferior and 
temporal fields; emulsified silicon oil in the 
superior field; LE multiple anterior synechiae 
nasal, pigmentary dispersion inferior, temporal 
and superior fields. 
  Anterior pole RE: Ahmed valve covered with 
conjunctiva, functional filtering bulb, the tube 
present in anterior chamber, unblocked by 
emulsified silicon oil, transparent cornea, clear 
aqueous humor, without dyplopia. 
  Ultrasound examination: RE attached retina 
Discussions 
  This is the case of a patient with low grade 
myopia, who, after cataract surgery, developed retinal 
detachment. The retina was successfully reattached but, 
as a complication of intraocular presence of silicone oil, 
secondary glaucoma developed. Glaucoma did not 
respond to traditional medication.  
The IOP was elevated in the morning, probably 
related to the supine position and the presence of 
emulsified oil bubbles at the angle. The particularity of the 
case is that the patient had a cluster angle, with 
pigmentary dispersion and anterior synechiae at BE. An 
Ahmed valve implanted was successfully performed, 
using a traditional operative technique; postoperative 
complications were minimal and resolved. 
Conclusions 
  The Ahmed valve may be a solution for patients 
with secondary glaucoma after vitroretinal surgery when 
medication is not effective. Because of the valve 
mechanism, intraocular pressure does not decrease as 
fast as it does after trabeculectomy, so the risk of retinal 
redetachment is lower. Most surgeons recommend 
Ahmed valve as a last therapeutic solution for refractory 
glaucoma after repeated trabeculectomy. During the three 
decades that have passed after the approval of this 
device, developed by Molteno, the indications for artificial 
devices changed. Currently, artificial drainage systems 
can be used successfully for secondary glaucoma after 
vitreoretinal surgery, neovascular glaucoma and 
inflammatory glaucoma. 
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